Carmen Hodel, Federico Moccetti, Stephanie Brunner, Valentin Sandoz, Lucca Loretz, Mathias Wolfrum, Stefan Toggweiler
{"title":"Long-Term Outcomes After Transcatheter Aortic Valve Replacement Complicated by New-Onset Persistent Left Bundle Branch Block","authors":"Carmen Hodel, Federico Moccetti, Stephanie Brunner, Valentin Sandoz, Lucca Loretz, Mathias Wolfrum, Stefan Toggweiler","doi":"10.1002/ccd.31491","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Long-term data on the relevance of new-onset persistent left bundle branch block (pLBBB) after transcatheter aortic valve replacement (TAVR) are sparse. This study aimed to assess the impact of pLBBB that occurs after TAVR on mortality, hospitalisation for heart failure, new permanent pacemaker (PPM) implantation, and left ventricular ejection fraction (LV-EF).</p>\n </section>\n \n <section>\n \n <h3> Aims</h3>\n \n <p>To investigate the impact of pLBBB on long-term outcomes after TAVR.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>After exclusion of patients with baseline conduction disorders, a pre-existing PPM, valve-in-valve treatment, or in-hospital mortality, a total of 551 patients were analysed. Patients were divided into two groups (pLBBB and no/transient LBBB) and followed over 5 years.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A pLBBB occurred in 85 patients (15%). Patients with pLBBB had a significantly deeper valve implantation (4.0 ± 1.8 mm vs. 3.3 ± 1.8 mm, <i>p</i> < 0.01). pLBBB was associated with an increased risk for hospitalisation for heart failure (HR<sub>adjusted</sub> 1.34, 95% CI 1.01−1.76, <i>p</i> = 0.04), whereas all-cause mortality was not elevated. The presence of pLBBB was linked to a significant decline in LV-EF over the follow-up period (58% ± 11% to 55% ± 12%, <i>p</i> = 0.03). There was a trend toward more new PPM implantation but no significant difference (HR<sub>adjusted</sub> 1.45, 95% CI 0.96−2.18, <i>p</i> = 0.07). A transient LBBB did not affect the studied outcomes.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>During long-term follow-up, patients with a pLBBB were more often hospitalised for heart failure, and experienced a significant reduction in LV-EF in comparison to patients with no or only transient LBBB.</p>\n </section>\n </div>","PeriodicalId":9650,"journal":{"name":"Catheterization and Cardiovascular Interventions","volume":"105 7","pages":"1545-1551"},"PeriodicalIF":1.9000,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Catheterization and Cardiovascular Interventions","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ccd.31491","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Long-term data on the relevance of new-onset persistent left bundle branch block (pLBBB) after transcatheter aortic valve replacement (TAVR) are sparse. This study aimed to assess the impact of pLBBB that occurs after TAVR on mortality, hospitalisation for heart failure, new permanent pacemaker (PPM) implantation, and left ventricular ejection fraction (LV-EF).
Aims
To investigate the impact of pLBBB on long-term outcomes after TAVR.
Methods
After exclusion of patients with baseline conduction disorders, a pre-existing PPM, valve-in-valve treatment, or in-hospital mortality, a total of 551 patients were analysed. Patients were divided into two groups (pLBBB and no/transient LBBB) and followed over 5 years.
Results
A pLBBB occurred in 85 patients (15%). Patients with pLBBB had a significantly deeper valve implantation (4.0 ± 1.8 mm vs. 3.3 ± 1.8 mm, p < 0.01). pLBBB was associated with an increased risk for hospitalisation for heart failure (HRadjusted 1.34, 95% CI 1.01−1.76, p = 0.04), whereas all-cause mortality was not elevated. The presence of pLBBB was linked to a significant decline in LV-EF over the follow-up period (58% ± 11% to 55% ± 12%, p = 0.03). There was a trend toward more new PPM implantation but no significant difference (HRadjusted 1.45, 95% CI 0.96−2.18, p = 0.07). A transient LBBB did not affect the studied outcomes.
Conclusions
During long-term follow-up, patients with a pLBBB were more often hospitalised for heart failure, and experienced a significant reduction in LV-EF in comparison to patients with no or only transient LBBB.
背景:经导管主动脉瓣置换术(TAVR)后新发持续性左束支阻滞(pLBBB)相关性的长期数据很少。本研究旨在评估TAVR后发生pLBBB对死亡率、心力衰竭住院率、新型永久起搏器(PPM)植入和左心室射血分数(LV-EF)的影响。目的:探讨pLBBB对TAVR术后长期预后的影响。方法:在排除基线传导障碍、预先存在的PPM、瓣膜内治疗或住院死亡率的患者后,共分析551例患者。患者分为两组(pLBBB和无/短暂性LBBB),随访5年以上。结果:85例(15%)患者发生pLBBB。pLBBB患者瓣膜置入术深度明显加深(4.0±1.8 mm vs 3.3±1.8 mm, p校正1.34,95% CI 1.01-1.76, p = 0.04),而全因死亡率没有升高。pLBBB的存在与随访期间LV-EF的显著下降有关(58%±11%至55%±12%,p = 0.03)。新的PPM植入有增加的趋势,但差异无统计学意义(hrp调整为1.45,95% CI 0.96 ~ 2.18, p = 0.07)。短暂性脑卒中不影响研究结果。结论:在长期随访中,与没有或只有短暂性LBBB的患者相比,pLBBB患者更常因心力衰竭住院,并且LV-EF显著降低。
期刊介绍:
Catheterization and Cardiovascular Interventions is an international journal covering the broad field of cardiovascular diseases. Subject material includes basic and clinical information that is derived from or related to invasive and interventional coronary or peripheral vascular techniques. The journal focuses on material that will be of immediate practical value to physicians providing patient care in the clinical laboratory setting. To accomplish this, the journal publishes Preliminary Reports and Work In Progress articles that complement the traditional Original Studies, Case Reports, and Comprehensive Reviews. Perspective and insight concerning controversial subjects and evolving technologies are provided regularly through Editorial Commentaries furnished by members of the Editorial Board and other experts. Articles are subject to double-blind peer review and complete editorial evaluation prior to any decision regarding acceptability.